Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Experimental Parasitology|July 7, 2007
Antiplasmodial structure-activity relationship of 3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-di-N-oxide derivativesAdoración Marin, Lidia Moreira Lima, Beatriz Solano, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|April 25, 2024
Prioritization of initiatives 2024-2027 of the strategic map of pharmaceutical outpatient care of the Spanish Society of Hospital PharmacyRamón Morillo Verdugo, Beatriz Bernardez Ferrán, Aurora Fernández Polo, et al.
Molecules (Basel, Switzerland)|February 9, 2008
Synthesis and antiplasmodial activity of 3-furyl and 3-thienylquinoxaline-2-carbonitrile 1,4-di-N-oxide derivativesEsther Vicente, Sarah Charnaud, Emily Bongard, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|October 3, 2024
[Translated article] Prioritisation of 2024-2027 initiatives of the strategic Map for outpatient pharmaceutical care of the Spanish Society of Hospital PharmacyRamón Morillo Verdugo, Beatriz Bernardez Ferrán, Aurora Fernández Polo, et al.
Journal of Clinical Pharmacy and Therapeutics|December 5, 2022
Six months multicentre pilot open label single-arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled syringe or autoinjection pen to an AVA® e-Device in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis patientsJoaquin Borrás-Blasco, Esther Vicente-Escrig, Francisco José Rodríguez-Lucena, et al.
European Journal of Medicinal Chemistry|January 25, 2008
Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agentsEsther Vicente, Lidia M Lima, Emily Bongard, et al.
Memorias Do Instituto Oswaldo Cruz|January 17, 2009
Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivativesAsunción Burguete, Yannick Estevez, Denis Castillo, et al.
The Journal of Investigative Dermatology|April 25, 2018
Deregulated PSGL-1 Expression in B Cells and Dendritic Cells May Be Implicated in Human Systemic Sclerosis DevelopmentJavier Silván, Rafael González-Tajuelo, Esther Vicente-Rabaneda, et al.
Journal of Medicinal Chemistry|October 4, 2007
Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analoguesBeatriz Solano, Venkatraman Junnotula, Adoración Marín, et al.
The Journal of Antimicrobial Chemotherapy|May 27, 2008
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxideRaquel Villar, Esther Vicente, Beatriz Solano, et al.
Pageof 8